Depression Treatment Market Size – USD 12.06 Billion in 2019, Market Growth - CAGR of 3.9%

VANCOUER, BC, CANADA, May 24, 2022 /EINPresswire.com/ -- The global Depression Treatment Market is forecasted to be worth USD 16.06 Billion by 2027, according to a current analysis by Emergen Research. The growing incidence of mental health and depression is creating a demand for the market. Growth in the geriatric population and the rise in diseases such as anxiety disorders, phobia, and dementia will impact market growth. The low cost of the medication, coupled with affordable therapies, are expected to propel the growth of the Depression Treatment market.

The report, published by Emergen Research , is a detail-oriented compilation of the crucial aspects of the Depression Treatment Market , including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬 𝐆𝐞𝐭 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.emergenresearch.com/request-sample/191

Major Depressive Disorder (MDD), also known as clinical depression, is a condition that impacts behavior and mood as well as physical functions, like appetite and sleep. It is among the most common mental health condition, and studies suggest that almost 7% of the adults in the United States suffered from the disease in 2017.

A major driving factor of the market is a surge in generic drug manufacturers. The lower cost of antidepressants and other drugs has encouraged people to opt for the treatment. Moreover, a rise in awareness about the treatment is also encouraging people to opt for the procedure. Rising awareness has led people to gather more knowledge about the disease and get rid of the old stigma attached to it. People are understanding the need for treatment and opting for it for a healthier lifestyle.

𝐒𝐨𝐦𝐞 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 :

In October 2020, a global biotech company, ATAI Life Sciences, has launched Viridia Life Sciences for the development of formulations of N, N-dimethyltryptamine (DMT) to investigate the efficiency of digital therapeutics with resistant depression.

Antipsychotics treatment has been used to treat depressive disorders. The medicine was used in combination with antidepressants and became the choice of treatment for depressed patients who had psychotic symptoms. The antipsychotic treatment was done to treat symptoms such as delusions, hallucinations, or marina symptoms. It is also used to treat bipolar depression.

Hospitals held the largest share in the year 2019 as most of the depressed cases were recognized when registered at a hospital for treatment. Not many are aware of their symptoms and visit hospitals to get treated when the situation become a little extreme. There are also special wards and doctors for patients who are going through depression during their treatment.

The market for depression treatment in North America is driven by a high level of awareness and availability of drugs and therapies. The region also has a level of depression treatment facilities, increased funding for research, and the presence of major market players.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 :

𝐓𝐡𝐞 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐯𝐞𝐧𝐝𝐨𝐫𝐬’ 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐥𝐚𝐮𝐧𝐜𝐡𝐞𝐬, 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲, 𝐚𝐧𝐝 𝐩𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬, 𝐬𝐮𝐜𝐡 𝐚𝐬: Pfizer, Inc., AstraZeneca, Plc, GlaxoSmithKline Plc, Eily, Lilly, and Company, Allergan Plc, Takeda Pharmaceutical Company Limited, Intellipharmaceutics International, Inc., Otsuka Holdings Co. Ltd., H.Lundbeck A/S, and Apotex, Inc

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐯𝐢𝐬𝐢𝐭 @ https://www.emergenresearch.com/industry-report/depression-treatment-market

The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Depression Treatment Market market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities.

𝐅𝐨𝐫 𝐭𝐡𝐞 𝐩𝐮𝐫𝐩𝐨𝐬𝐞 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐨𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐝𝐫𝐮𝐠 𝐭𝐲𝐩𝐞, 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐞𝐧𝐝-𝐮𝐬𝐞𝐫, 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐧𝐧𝐞𝐥, 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧:

Drug Type Outlook (Revenue, USD Billion; 2017-2027)
Antidepressants
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Modulators
Tricyclic & Tetracyclic Antidepressants
Atypical Antidepressants
Antipsychotics
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Major Depressive Disorder (MDD)
Bipolar Disorder
Postpartum Depression
Premenstrual Dysphoric Disorder (PMDD)
Dysthymic Disorder
Seasonal Affective Disorder (SAD)
Others

End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
NGOs
Mental Health Centers
Asylums
Others

Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Hospitals Pharmacies
Retail Pharmacies
Online

𝐁𝐮𝐲 𝐍𝐨𝐰 @ https://www.emergenresearch.com/select-license/191

𝐑𝐞𝐠𝐢𝐨𝐧 𝐰𝐢𝐬𝐞 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

North America Depression Treatment Market forecast is expected to remain significantly positive in terms of revenue share between 2020 and 2027. In addition, North America Depression Treatment Market revenue share is expected to remain comparatively larger than that of other regional markets from 2020 to 2027.

Asia Pacific registered fastest revenue CAGR in 2020, and the Depression Treatment Market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2027.

Europe Depression Treatment Market forecast is positive currently, with revenue growth expected to remain steady between 2020 and 2027. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Depression Treatment Market growth

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐦𝐨𝐫𝐞 𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 @

ozone generator market @ https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/ozone-generator-market

topical drug delivery market @ https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/topical-drug-delivery-market

joint reconstruction market @ https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/joint-reconstruction-market

plant genomics market @ https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/plant-genomics-market

blood pressure monitoring devices market @ https://www.google.com.ai/url?q=https://www.emergenresearch.com/industry-report/blood-pressure-monitoring-devices-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Depression Treatment Market Study Reports : Increase in depression among millennials

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.